{"tm":1686888636,"s":"ACRS","news":[{"t":"Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences","dt":"Jun-02-23 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-two-june-110000102.html"},{"t":"Q1 2023 Aclaris Therapeutics Inc Earnings Call","dt":"May-08-23 11:55PM","a":"Thomson Reuters StreetEvents","u":"https:\/\/finance.yahoo.com\/news\/q1-2023-aclaris-therapeutics-inc-035500677.html"},{"t":"Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update","dt":"07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-reports-first-quarter-110000777.html"},{"t":"Foghorn Therapeutics Inc. (FHTX) Soars 13.1%: Is Further Upside Left in the Stock?","dt":"Apr-27-23 04:35AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/foghorn-therapeutics-inc-fhtx-soars-083508488.html"},{"t":"Aclaris Therapeutics to Participate in the H.C. Wainwright Autoimmune &amp; Inflammatory Disease Virtual Conference","dt":"Mar-27-23 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-h-c-110000415.html"},{"t":"These 2 Biotech Stocks Made Big Monday Moves","dt":"02:32PM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/18e5b8d0-74f5-3c71-9808-fe7adc4c04cc\/these-2-biotech-stocks-made.html"},{"t":"Aclaris Therapeutics Announces Preliminary Topline Data from 12-Week Phase 2a Study of Oral Zunsemetinib (ATI-450) for Moderate to Severe Hidradenitis Suppurativa","dt":"07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-announces-preliminary-topline-120000804.html"},{"t":"Investing in Aclaris Therapeutics (NASDAQ:ACRS) three years ago would have delivered you a 943% gain","dt":"Feb-22-23 06:01AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/investing-aclaris-therapeutics-nasdaq-acrs-110122545.html"},{"t":"Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China","dt":"Nov-29-22 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-pediatrix-therapeutics-announce-120000854.html"},{"t":"Aclaris Therapeutics Looks Promising on the Charts","dt":"Nov-16-22 12:10PM","a":"TheStreet.com","u":"https:\/\/finance.yahoo.com\/m\/fcad6609-5b6f-32f0-b2ae-f5447b76ed42\/aclaris-therapeutics-looks.html"},{"t":"Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update","dt":"07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-reports-third-quarter-120000871.html"},{"t":"Aclaris Therapeutics (NASDAQ:ACRS) pulls back 7.4% this week, but still delivers shareholders massive 110% CAGR over 3 years","dt":"Sep-15-22 06:46AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-nasdaq-acrs-pulls-104654911.html"},{"t":"Health Check: How Prudently Does Aclaris Therapeutics (NASDAQ:ACRS) Use Debt?","dt":"Aug-05-22 07:59AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/health-check-prudently-does-aclaris-115923266.html"},{"t":"Aclaris Therapeutics Expands Leadership Team","dt":"Aug-01-22 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-expands-leadership-team-110000026.html"},{"t":"Lab Notes: Verrica continues push for skin disorder drug, raising $25M; Windtree weighing options","dt":"Jul-01-22 09:36AM","a":"American City Business Journals","u":"https:\/\/www.bizjournals.com\/philadelphia\/news\/2022\/07\/01\/lab-notes-verrica-windtree-inovio-aclaris-xylocor.html?utm_source=sy&utm_medium=nsyp&utm_campaign=yh"},{"t":"Aclaris (ACRS) Moves 5.5% Higher: Will This Strength Last?","dt":"Jun-20-22 08:20AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/aclaris-acrs-moves-5-5-122012144.html"},{"t":"Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference","dt":"Jun-01-22 04:01PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-jefferies-healthcare-200100236.html"},{"t":"Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference","dt":"May-16-22 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-h-c-110000523.html"},{"t":"Lannett (LCI) Reports Q3 Loss, Lags Revenue Estimates","dt":"May-04-22 07:35PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/lannett-lci-reports-q3-loss-233511505.html"},{"t":"FEC Resources Reports on SC 72 Force Majeure Declaration","dt":"Apr-13-22 12:17AM","a":"Newsfile","u":"https:\/\/finance.yahoo.com\/news\/fec-resources-reports-sc-72-041700192.html"},{"t":"Those who invested in Aclaris Therapeutics (NASDAQ:ACRS) three years ago are up 97%","dt":"Feb-21-22 04:34AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/those-invested-aclaris-therapeutics-nasdaq-093432765.html"},{"t":"Aclaris Therapeutics to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference","dt":"Feb-02-22 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-svb-leerink-120000548.html"},{"t":"Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference","dt":"Dec-27-21 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-h-c-120000054.html"},{"t":"Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine","dt":"Dec-03-21 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-announces-publication-preclinical-120000271.html"},{"t":"Aclaris Therapeutics to Participate in Upcoming Investor Conferences","dt":"Nov-03-21 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-upcoming-investor-110000780.html"},{"t":"Analysts Estimate Aclaris Therapeutics (ACRS) to Report a Decline in Earnings: What to Look Out for","dt":"Oct-27-21 03:03PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/analysts-estimate-aclaris-therapeutics-acrs-190307681.html"},{"t":"Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Aclaris Therapeutics, Inc.  ACRS","dt":"Sep-20-21 08:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/pomerantz-llp-announces-proposed-class-120000436.html"},{"t":"Should You Buy Aclaris Therapeutics (ACRS) Ahead of Earnings?","dt":"Aug-05-21 10:58AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/buy-aclaris-therapeutics-acrs-ahead-145802986.html"},{"t":"Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021","dt":"Jul-08-21 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-william-blair-110000246.html"},{"t":"Aclaris Announces Pricing of Public Offering of Common Stock","dt":"Jun-09-21 07:55PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-announces-pricing-public-offering-235500413.html"},{"t":"Aclaris' ATI-1777 Aces Atopic Dermatitis Trial with Minimal Systemic Exposure","dt":"07:46AM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/aclaris-ati-1777-aces-atopic-114641962.html"},{"t":"Aclaris Therapeutics to Participate in the Jefferies Virtual Healthcare Conference","dt":"May-17-21 07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-participate-jefferies-virtual-110000694.html"},{"t":"Aclaris Therapeutics (ACRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release","dt":"Apr-29-21 05:02PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/aclaris-therapeutics-acrs-may-report-210209111.html"}]}